CNQ · MVMD.CN
Mountain Valley MD Holdings Inc.
CA$0.07+CA$0.01 (+7.69%)
Mountain Valley MD Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.33% below the high.
Loading market information…
TSXV · AVCR.V · CAD
Stock price, earnings
Quote as of Oct 29, 2026, 02:46 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Avricore Health Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Avricore Health Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Avricore Health Inc. operates within Canada, specializing in health data management and point-of-care technological solutions. Their primary offering is HealthTab, a precise, laboratory-quality diagnostic testing system designed for use in pharmacies. This enterprise maintains key alliances with prominent organizations such as Shoppers Drug Marts and Abbott. Established in 1996 and headquartered in Vancouver, Canada, the company previously operated as Vanc Pharmaceuticals Inc., adopting its current name, Avricore Health Inc., in October 2018.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:12 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.07+CA$0.01 (+7.69%)
Mountain Valley MD Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.33% below the high.
CA$0.04CA$0.00 (0.0%)
Kane Biotech Inc.’s quoted price sits in the upper half of its reported 52-week range, 30.0% below the high.
CA$0.02-CA$0.01 (-25.0%)
Revive Therapeutics Ltd.’s quoted price sits in the lower half of its reported 52-week range, 81.25% below the high.
CA$2.40CA$0.00 (0.0%)
Aptose Biosciences Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.23% below the high.
CA$0.11+CA$0.01 (+10.0%)
Mercanto Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 35.29% below the high.
CA$0.01CA$0.00 (0.0%)
1933 Industries Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
CA$0.05CA$0.00 (0.0%)
Telo Genomics Corp.’s quoted price sits in the lower half of its reported 52-week range, 52.38% below the high.
$0.03$0.00 (0.0%)
CordovaCann Corp.’s quoted price sits in the lower half of its reported 52-week range, 57.14% below the high.
